continu pattern strong execut
remain top pick among provid
double-digit ebitda growth strong outlook
solid cap year revenu growth ebitda growth
compani grew ss equival admiss target rang
grew revenu per equival admiss within target rang full
year inpati outpati surgeri grew respect hca
outlook impli ebitda growth exclud mln payer settlement
includ least contribut acquisit complet
capit deploy opportun end year net debt ebitda
compani target rang lowest sinc
compani brought public expect compani gener
bln nci distribut dividend remain
bln leav plenti capac compani acceler share
repurchas total bln pursu larg acquisit
increas share repurchas author bln total bln manag
said continu look coupl larger deal whether come
fruition time still unknown
in-network contract la vega said lot medic staff
particip in-network basi alreadi hca new in-network
relationship market provid opportun clinician take care
full patient load within facil manag view new contract
la vega materi specif market less materi whole
physician strategi ed anesthesiolog hospitalist manag continu
consid whether make sens employ physician contract abil
either larg contract outsid organ specialti current
valuat rais tp base
ebitda estimate bln prev bln estimate reflect ebitda growth
consist compani guidanc estim reflect ebitda growth
valuat metric
number share
 close
legal entiti disclosur statu non-u analyst us disclosur credit suiss seek busi
compani cover research report result investor awar firm may conflict interest could
affect object report investor consid report singl factor make invest decis
charl martineau univers toronto risk includ volum trend regulatori chang drag develop
price
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
one nation lead provid healthcar
servic oper local manag hospit freestand surgeri
center unit state unit kingdom
blue sky valuat equat blue sky
ebitda driven better expect volum margin trend
stronger free cash flow gener better capit deploy
grey sky valuat equat grey sky ebitda
driven rise competit market share loss reimburs
cut volum pressur includ potenti advers impact
repeal replac afford act
 close
compani mention price
 rice certifi view express report accur reflect person view subject compani
secur part compens directli indirectli relat specif recommend view express
report
